VEGFA and metabolic dysfunction-associated steatotic liver disease: Furthermore, in livers of NAFLD patients, we observed a correlation between the expression of vWF and the expression of collagen XV, a specific marker of portal myofibroblasts, that have proangiogenic properties, notably by secreting VEGF-containing extracellular vesicles [14].